Simplex Trading’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,500
| Closed | -$6K | – | 10714 |
|
|
2022
Q3 | $6K | Sell |
1,500
-200
| -12% | -$847 | ﹤0.01% | 8704 |
|
|
2022
Q2 | $6K | Buy |
1,700
+200
| +13% | +$570 | ﹤0.01% | 8767 |
|
|
2022
Q1 | $7K | Sell |
1,500
-900
| -38% | -$2.71K | ﹤0.01% | 9227 |
|
|
2021
Q4 | $8K | Buy |
2,400
+1,400
| +140% | +$7.47K | ﹤0.01% | 9243 |
|
|
2021
Q3 | $12K | Hold |
1,000
| – | – | ﹤0.01% | 8844 |
|
|
2021
Q2 | $11K | Buy |
1,000
+998
| +49,900% | +$10K | ﹤0.01% | 9061 |
|
|
2021
Q1 | $1K | Buy |
+2
| New | +$21 | ﹤0.01% | 8593 |
|
|
2020
Q1 | – | Sell |
-1
| Closed | -$1K | – | 8432 |
|
|
2019
Q4 | $1K | Hold |
1
| – | – | ﹤0.01% | 7145 |
|
|
2019
Q3 | $2K | Hold |
1
| – | – | ﹤0.01% | 6975 |
|
|
2019
Q2 | $1K | Sell |
1
-5
| -83% | -$193 | ﹤0.01% | 6924 |
|
|
2019
Q1 | $27K | Buy |
+6
| New | +$136 | ﹤0.01% | 5507 |
|
|
2018
Q4 | – | Sell |
-6
| Closed | -$40K | – | 7977 |
|
|
2018
Q3 | $40K | Buy |
+6
| New | +$456 | ﹤0.01% | 5385 |
|
|
2018
Q2 | – | Sell |
-1
| Closed | -$89 | – | 7218 |
|
|
2018
Q1 | $7K | Buy |
+1
| New | +$171 | ﹤0.01% | 4388 |
|
|
2017
Q1 | – | Sell |
-1
| Closed | -$1K | – | 6910 |
|
|
2016
Q4 | $1K | Hold |
1
| – | – | ﹤0.01% | 5557 |
|
|
2016
Q3 | $2K | Buy |
+1
| New | +$141 | ﹤0.01% | 5091 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 4134 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 3839 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 3920 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 4445 |
|
|
2015
Q1 | – | Sell |
-1
| Closed | -$2K | – | 5731 |
|
|
2014
Q4 | $2K | Buy |
+1
| New | +$451 | ﹤0.01% | 3849 |
|
Simplex Trading's VIRX Position: Q2 2025 in Review
Simplex Trading sold out of Viracta Therapeutics, Inc. Common Stock (VIRX) in Q2 2025, closing a stake of 400 shares.
Simplex Trading first reported a position in VIRX in Q3 2015 and held it in 23 quarters. The position peaked at $96K in Q1 2017. 0 funds tracked by Wall St. Rank hold VIRX as of Q2 2025.
- Simplex Trading reported no remaining Viracta Therapeutics, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
- Simplex Trading sold 400 Viracta Therapeutics, Inc. Common Stock shares in Q2 2025.
- Simplex Trading first reported a position in Viracta Therapeutics, Inc. Common Stock in Q3 2015 and held it in 23 quarters.
- Simplex Trading's Viracta Therapeutics, Inc. Common Stock position peaked at $96K in Q1 2017.
- 0 funds tracked by Wall St. Rank held Viracta Therapeutics, Inc. Common Stock as of Q2 2025.
Based on Simplex Trading's 13F filing for Q2 2025, filed 5 Aug 2025.